26Jul 2017

ACUTE PANCREATITIS AFTER TRANSARTERIAL CHEMOEMBOLIZATION BEFORE LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: A CASE REPORT.

  • Department of Gastroenterology I, Mohamed V Military Hospital, Rabat, Morocco.
  • Department of Radiology, Mohamed V Military Hospital, Rabat, Morocco.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Acute pancreatitis is one of the rare complications of transcatheter arterial chemoembolization with an incidence ranging from 2% (clinical pancreatitis) to 40% (biological pancreatitis). It may result from the development of ischemia caused by regurgitation of embolic materials into the vessels supplying the pancreas. This complication has a significant morbidity and mortality potential when it is associated with other complications. Case report: We report a case of acute pancreatitis in a 58 year-old North African male, developed within 24h after a first selective chemoembolization proposed as locoregional bridge therapy for the treatment of hepatocellular carcinoma before liver transplantation. In this case, the first possible etiology of acute pancreatitis was transcatheter arterial chemoembolization, because there were no other causes of acute pancreatitis, the chronology was compatible and the vascular opacification has showed a regurgitation of embolic materials during the procedure .Through this case and review of literature, we focused on the mechanisms and diagnosis difficulties of acute pancreatitis following chemoembolization. Conclusion: Acute pancreatitis is a rare complication of transcatheter arterial chemoembolization, and may clinically mimic a postembolization syndrome at the early stage. The knowledge of this complication must lead to a systematic monitoring of serum pancreatic enzymes in cases of abdominal pain after chemoembolization.


  1. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized cntrolled trials. Radiology 2002;224:47?54.
  2. Toso C, Mentha G, Kneteman NM, Majno P (2010) The place of downstaging for hepatocellular carcinoma. J Hepatol 52:930?936. doi:10.1016/j.jhep.2009.12.032
  3. L?pez-Ben?tez R, Radeleff BA, Barrag?n-Campos HM, Noeldge G Grenacher L, Richter GM, et al. Acute pancreatitis after embolization of liver tumors: frequency and associated risk factors. Pancreatology 2007;7:53-62.
  4. McGlynn?KA, London?WT.?Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res ClinGastroenterol?2005;19(1):3?23.?CrossRef,?Medline.
  5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693?699.
  6. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumour size limits does not adversely impact survival. Hepatology 2001; 33:1394?1403.
  7. Llovet JM, Real MI, Monta?a X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359 :1734-1739.
  8. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarteriallipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171.
  9. Xia J, Ren Z, Ye S, et al. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol 2006; 59:407?12.
  10. Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC: Determinants of postembolization syndrome after hepatic chemoembolization. J VascIntervRadiol 2001; 12:321?326.
  11. Kolmannskog F, Kolbenstvedt AN, Schrumpf E, Hanssen LE: Side effects and complications after hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol 1991; 26:557?562.
  12. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998; 18:605-619.
  13. Oz?inar B, G?ven K, Poyanli A, Ozden I. Necrotizing pancreatitis after transcateter arterial chemoembolization for hepatocellular carcinoma. DiagnIntervRadiol 2009; 15:36-38.
  14. Addario L, Di Costanzo GG, Tritto G, Cavagli? E, Angrisani B, Ascione A. Fatal ischemic acute pancreatitis complicating transcatheter arterial embolization of small hepatocellular carcinoma: do the risks outweigh the benefits? J Hepatol 2008
  15. Khan KN, Nakata K, Shima M, Kusumoto Y, Nobuko I, Koji T, et al. Pancreatic tissue damage by transcatheter arterial embolization for hepatoma. Dig Dis Sci 1993;38:65?70.
  16. Komekado H, Kokuryu H, Kimura T, Maruo T, Kita R, Osaki Y, et al. Two cases of acute necrotizing pancreatitis complicating after transcatheter arterial embolization for hepatocellular carcinoma. J Gastroenterol 2005; 40:107-108.

[Hanane BASR, Rachida SAOUAB, Brahim AITBIHI, Mohamed MAHI and Fedoua ROUIBAA. (2017); ACUTE PANCREATITIS AFTER TRANSARTERIAL CHEMOEMBOLIZATION BEFORE LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: A CASE REPORT. Int. J. of Adv. Res. 5 (Jul). 1922-1926] (ISSN 2320-5407). www.journalijar.com


BASR Hanane
Mohamed V Military Hospital ,RABAT,Morocco

DOI:


Article DOI: 10.21474/IJAR01/4922      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4922